We found no statistical differences in the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and blood urea nitrogen (BUN) between the control and MG-treated groups at Weeks 8 and 17 (Figure S1). The gene discussed is GPT; the disease is myasthenia gravis.